| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | MYC KMT2D HIVEP1 ZBTB48 NFATC3 ZSCAN5A GLI1 HLF HLX MAFB TSHZ1 DLX5 SOX8 TCF7L1 SIX2 MYB | 1.50e-04 | 1412 | 81 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.30e-04 | 303 | 81 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 4.36e-04 | 560 | 81 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | MYC HIVEP1 ZBTB48 NFATC3 ZSCAN5A GLI1 HLF MAFB DLX5 SOX8 KDM6B TCF7L1 SIX2 MYB | 4.42e-04 | 1244 | 81 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.48e-04 | 8 | 81 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.71e-04 | 566 | 81 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | MYC HIVEP1 ZBTB48 NFATC3 ZSCAN5A GLI1 HLF MAFB DLX5 SOX8 KDM6B TCF7L1 SIX2 MYB | 5.48e-04 | 1271 | 81 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | MYC HIVEP1 ZBTB48 NFATC3 ZSCAN5A GLI1 HLF MAFB DLX5 SOX8 KDM6B CREBBP TCF7L1 SIX2 MYB | 6.98e-04 | 1459 | 81 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 7.16e-04 | 10 | 81 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.55e-04 | 44 | 81 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | transcription factor binding | 9.17e-04 | 753 | 81 | 10 | GO:0008134 | |
| GeneOntologyBiologicalProcess | embryo development | MYC KMT2D MICAL2 GLI1 CECR2 KIAA1217 DZIP1L HLX AMBRA1 MAFB TSHZ1 PDZD7 DLX5 ZMIZ1 SOX8 KDM6B ARID1A TDRD1 CREBBP TCF7L1 SIX2 MYB SOS1 | 3.88e-09 | 1437 | 81 | 23 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | MYC MICAL2 GLI1 CECR2 HLX MAFB TSHZ1 PDZD7 DLX5 SOX8 KDM6B ARID1A CREBBP SIX2 SOS1 | 1.02e-07 | 713 | 81 | 15 | GO:0048598 |
| GeneOntologyBiologicalProcess | cytoplasm organization | 6.48e-07 | 18 | 81 | 4 | GO:0007028 | |
| GeneOntologyBiologicalProcess | epithelium development | MYC NFATC3 TMEM132E MICAL2 GLI1 CECR2 DZIP1L PUM2 AMBRA1 MAFB PDZD7 BCL2 DLX5 SOX8 BRSK1 KDM6B ARID1A ADAMTSL4 SIX2 SOS1 | 6.96e-07 | 1469 | 81 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | sensory organ development | MYC KMT2C TMEM132E CECR2 MAFB TSHZ1 PDZD7 BCL2 DLX5 SOX8 ARID1A SIX2 ARHGEF15 SOS1 | 8.67e-07 | 730 | 81 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.15e-06 | 351 | 81 | 10 | GO:0048562 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.46e-06 | 382 | 81 | 10 | GO:0030217 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 3.17e-06 | 306 | 81 | 9 | GO:0044843 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MYC KMT2C KMT2D HIVEP1 NFATC3 MICAL2 GLI1 HLF AKNA MAFB DLX5 ZMIZ1 SOX8 KDM6B CREBBP TCF7L1 SIX2 MYB | 5.71e-06 | 1390 | 81 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 7.98e-06 | 343 | 81 | 9 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to ischemia | 9.38e-06 | 72 | 81 | 5 | GO:0002931 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 1.12e-05 | 271 | 81 | 8 | GO:0000082 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.18e-05 | 561 | 81 | 11 | GO:0048568 | |
| GeneOntologyBiologicalProcess | ear development | 1.62e-05 | 285 | 81 | 8 | GO:0043583 | |
| GeneOntologyBiologicalProcess | T cell activation | MYC ARID1B NFATC3 CEACAM4 HLX AMBRA1 MAFB BCL2 ZMIZ1 ARID1A MYB SOS1 | 1.79e-05 | 701 | 81 | 12 | GO:0042110 |
| GeneOntologyBiologicalProcess | tube development | MYC NFATC3 MICAL2 GLI1 CECR2 DZIP1L ADGRB2 CEACAM4 HLX AMBRA1 BCL2 ZMIZ1 SOX8 ARID1A SIX2 MYB SOS1 | 2.56e-05 | 1402 | 81 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 2.77e-05 | 223 | 81 | 7 | GO:0007519 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 3.21e-05 | 154 | 81 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | MYC NFATC3 MICAL2 CECR2 BCL2 SOX8 BRSK1 KDM6B ARID1A TCF7L1 SIX2 SOS1 | 3.46e-05 | 750 | 81 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | MYC ARID1B NFATC3 HLX AMBRA1 MAFB BCL2 ZMIZ1 ARID1A MYB SOS1 | 3.98e-05 | 640 | 81 | 11 | GO:1903131 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.09e-05 | 237 | 81 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 4.43e-05 | 240 | 81 | 7 | GO:0060538 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.66e-05 | 242 | 81 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 4.71e-05 | 537 | 81 | 10 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 5.17e-05 | 246 | 81 | 7 | GO:1902806 | |
| GeneOntologyBiologicalProcess | head development | TTBK1 ATXN2 GLI1 AKNA MAST1 MAFB BCL2 DLX5 ZMIZ1 KDM6B ARID1A CREBBP SOS1 | 5.66e-05 | 919 | 81 | 13 | GO:0060322 |
| GeneOntologyBiologicalProcess | muscle tissue development | 6.49e-05 | 558 | 81 | 10 | GO:0060537 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 8.52e-05 | 59 | 81 | 4 | GO:0048546 | |
| GeneOntologyBiologicalProcess | vitellogenesis | 9.09e-05 | 4 | 81 | 2 | GO:0007296 | |
| GeneOntologyBiologicalProcess | thymus development | 9.71e-05 | 61 | 81 | 4 | GO:0048538 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | MYC NFATC3 MICAL2 GLI1 CECR2 ADGRB2 CEACAM4 HLX BCL2 ZMIZ1 SOX8 ARID1A SIX2 SOS1 | 1.13e-04 | 1125 | 81 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | brain development | TTBK1 ATXN2 GLI1 AKNA MAST1 MAFB BCL2 DLX5 ZMIZ1 KDM6B ARID1A SOS1 | 1.27e-04 | 859 | 81 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | middle ear morphogenesis | 1.42e-04 | 26 | 81 | 3 | GO:0042474 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.43e-04 | 614 | 81 | 10 | GO:0010720 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYC KMT2C ARID1B KMT2D BICRA CECR2 KDM6B KMT2E ARID1A TDRD1 CREBBP | 1.47e-04 | 741 | 81 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | branching involved in ureteric bud morphogenesis | 1.48e-04 | 68 | 81 | 4 | GO:0001658 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.52e-04 | 619 | 81 | 10 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 1.69e-04 | 627 | 81 | 10 | GO:0044770 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 1.71e-04 | 509 | 81 | 9 | GO:0044772 | |
| GeneOntologyBiologicalProcess | chromatin organization | MYC KMT2C ARID1B KMT2D BICRA CECR2 KDM6B KMT2E ARID1A TDRD1 CREBBP TCF7L1 | 1.87e-04 | 896 | 81 | 12 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.93e-04 | 213 | 81 | 6 | GO:2000045 | |
| GeneOntologyBiologicalProcess | leukocyte activation | MYC ARID1B TTBK1 NFATC3 CEACAM4 HLX AMBRA1 MAFB BCL2 ZMIZ1 KMT2E ARID1A MYB SOS1 | 1.96e-04 | 1186 | 81 | 14 | GO:0045321 |
| GeneOntologyBiologicalProcess | ureteric bud morphogenesis | 2.06e-04 | 74 | 81 | 4 | GO:0060675 | |
| GeneOntologyBiologicalProcess | cell activation | MYC ZP1 ARID1B TTBK1 NFATC3 CEACAM4 HLX AMBRA1 MAFB BCL2 ZMIZ1 KMT2E ARID1A MYB SOS1 | 2.28e-04 | 1356 | 81 | 15 | GO:0001775 |
| GeneOntologyBiologicalProcess | female gamete generation | 2.47e-04 | 223 | 81 | 6 | GO:0007292 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.47e-04 | 421 | 81 | 8 | GO:0060562 | |
| GeneOntologyBiologicalProcess | mesonephric tubule morphogenesis | 2.52e-04 | 78 | 81 | 4 | GO:0072171 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.52e-04 | 78 | 81 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | MYC ARID1B NFATC3 HLX AMBRA1 MAFB BCL2 ZMIZ1 ARID1A MYB SOS1 | 2.52e-04 | 789 | 81 | 11 | GO:0002521 |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.59e-04 | 144 | 81 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 2.64e-04 | 540 | 81 | 9 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.65e-04 | 226 | 81 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.80e-04 | 429 | 81 | 8 | GO:1902105 | |
| GeneOntologyBiologicalProcess | digestive tract development | 3.32e-04 | 152 | 81 | 5 | GO:0048565 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 3.49e-04 | 35 | 81 | 3 | GO:0048566 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 3.51e-04 | 85 | 81 | 4 | GO:0048146 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 3.80e-04 | 449 | 81 | 8 | GO:0050867 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 3.84e-04 | 87 | 81 | 4 | GO:0072078 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | MYC MICAL2 GLI1 HLX MAFB TSHZ1 PDZD7 BCL2 DLX5 ZMIZ1 SOX8 ARID1A SIX2 SOS1 | 3.90e-04 | 1269 | 81 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | lymphocyte activation | MYC ARID1B NFATC3 CEACAM4 HLX AMBRA1 MAFB BCL2 ZMIZ1 ARID1A MYB SOS1 | 4.09e-04 | 976 | 81 | 12 | GO:0046649 |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 4.18e-04 | 89 | 81 | 4 | GO:0072088 | |
| GeneOntologyBiologicalProcess | response to hypoxia | 4.37e-04 | 348 | 81 | 7 | GO:0001666 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.45e-04 | 162 | 81 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of kidney development | 4.46e-04 | 38 | 81 | 3 | GO:0090183 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 4.55e-04 | 91 | 81 | 4 | GO:0072028 | |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 4.94e-04 | 93 | 81 | 4 | GO:0061333 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MYC KMT2C ARID1B KMT2D BICRA CECR2 KDM6B KMT2E ARID1A TDRD1 CREBBP TCF7L1 | 5.04e-04 | 999 | 81 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | digestive system development | 5.11e-04 | 167 | 81 | 5 | GO:0055123 | |
| GeneOntologyBiologicalProcess | pigment cell differentiation | 5.19e-04 | 40 | 81 | 3 | GO:0050931 | |
| GeneOntologyBiologicalProcess | metanephros development | 5.36e-04 | 95 | 81 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 5.39e-04 | 9 | 81 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 5.71e-04 | 364 | 81 | 7 | GO:0036293 | |
| GeneOntologyBiologicalProcess | regionalization | 5.74e-04 | 478 | 81 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | positive regulation of gliogenesis | 6.02e-04 | 98 | 81 | 4 | GO:0014015 | |
| GeneOntologyBiologicalProcess | oocyte development | 6.26e-04 | 99 | 81 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 6.29e-04 | 266 | 81 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | MYC KMT2C OPTN KMT2D BICRA GLI1 HLX BCL2 DLX5 ZMIZ1 SOX8 SIX2 MYB | 7.07e-04 | 1190 | 81 | 13 | GO:0008284 |
| GeneOntologyBiologicalProcess | oocyte differentiation | 7.27e-04 | 103 | 81 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | central nervous system development | TTBK1 ATXN2 GLI1 AKNA MAST1 MAFB BCL2 DLX5 ZMIZ1 SOX8 KDM6B ARID1A SOS1 | 7.47e-04 | 1197 | 81 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of kidney development | 8.19e-04 | 11 | 81 | 2 | GO:0090184 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 8.38e-04 | 107 | 81 | 4 | GO:0001657 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 9.29e-04 | 110 | 81 | 4 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 9.29e-04 | 110 | 81 | 4 | GO:0072163 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 9.29e-04 | 110 | 81 | 4 | GO:0072080 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 9.44e-04 | 516 | 81 | 8 | GO:1901987 | |
| GeneOntologyBiologicalProcess | skeletal muscle fiber development | 9.44e-04 | 49 | 81 | 3 | GO:0048741 | |
| GeneOntologyBiologicalProcess | kidney morphogenesis | 9.61e-04 | 111 | 81 | 4 | GO:0060993 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.02e-03 | 402 | 81 | 7 | GO:1901990 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.03e-03 | 113 | 81 | 4 | GO:0001823 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 1.06e-03 | 114 | 81 | 4 | GO:0033077 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.07e-03 | 526 | 81 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.10e-03 | 198 | 81 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | regulation of cell development | MYC ARID1B TTBK1 HLX AMBRA1 MAFB BCL2 ZMIZ1 SOX8 ARID1A MYB SOS1 | 1.12e-03 | 1095 | 81 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | renal tubule development | 1.13e-03 | 116 | 81 | 4 | GO:0061326 | |
| GeneOntologyBiologicalProcess | regulation of somatic stem cell population maintenance | 1.16e-03 | 13 | 81 | 2 | GO:1904672 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.24e-03 | 119 | 81 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | myotube cell development | 1.25e-03 | 54 | 81 | 3 | GO:0014904 | |
| GeneOntologyBiologicalProcess | enteric nervous system development | 1.34e-03 | 14 | 81 | 2 | GO:0048484 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.37e-03 | 423 | 81 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | pigmentation | 1.49e-03 | 125 | 81 | 4 | GO:0043473 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.16e-05 | 12 | 80 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | chromatin | MYC ARID1B NFATC3 BICRA CECR2 HLF HLX MAFB TSHZ1 DLX5 ZMIZ1 SOX8 KMT2E ARID1A CREBBP TCF7L1 SIX2 | 3.63e-05 | 1480 | 80 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule organizing center | SPATC1 CDC42BPG EPS8L2 CFAP126 KIAA1217 DZIP1L AKNA MPLKIP KIF5B BRSK1 KMT2E FIGN NCKAP5L | 4.32e-05 | 919 | 80 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MYC KMT2C ARID1B KMT2D TINF2 BICRA CECR2 HLF MAFB NUP214 KDM6B KMT2E ARID1A CREBBP TCF7L1 MYB | 5.60e-05 | 1377 | 80 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | centrosome | SPATC1 CDC42BPG EPS8L2 KIAA1217 AKNA MPLKIP KIF5B BRSK1 KMT2E FIGN NCKAP5L | 1.63e-04 | 770 | 80 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.03e-04 | 30 | 80 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.49e-04 | 596 | 80 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.06e-04 | 96 | 80 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 6.17e-04 | 272 | 80 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | bBAF complex | 6.38e-04 | 10 | 80 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | methyltransferase complex | 7.88e-04 | 108 | 80 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | npBAF complex | 1.28e-03 | 14 | 80 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.28e-03 | 14 | 80 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.36e-03 | 317 | 80 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | ATPase complex | 1.52e-03 | 129 | 80 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | nBAF complex | 1.68e-03 | 16 | 80 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.58e-03 | 360 | 80 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | euchromatin | 2.66e-03 | 72 | 80 | 3 | GO:0000791 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.99e-03 | 75 | 80 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | stereocilium tip | 3.18e-03 | 22 | 80 | 2 | GO:0032426 | |
| MousePheno | abnormal ear morphology | 1.50e-05 | 470 | 68 | 11 | MP:0002102 | |
| MousePheno | decreased common myeloid progenitor cell number | 7.80e-05 | 47 | 68 | 4 | MP:0008813 | |
| MousePheno | abnormal facial morphology | EPS8L2 KMT2D NFATC3 CECR2 DZIP1L MPLKIP AMBRA1 TSHZ1 BCL2 DLX5 FIGN CREBBP SIX2 SOS1 | 1.00e-04 | 910 | 68 | 14 | MP:0003743 |
| MousePheno | abnormal inner ear morphology | 1.06e-04 | 303 | 68 | 8 | MP:0000026 | |
| MousePheno | abnormal otic capsule morphology | 1.38e-04 | 21 | 68 | 3 | MP:0000039 | |
| MousePheno | abnormal common myeloid progenitor cell morphology | 1.56e-04 | 105 | 68 | 5 | MP:0006410 | |
| MousePheno | pale yolk sac | 1.94e-04 | 110 | 68 | 5 | MP:0001722 | |
| MousePheno | abnormal craniofacial morphology | EPS8L2 KMT2D NFATC3 CECR2 HPS4 DZIP1L MPLKIP AMBRA1 MAFB TSHZ1 BCL2 DLX5 ZMIZ1 FIGN CREBBP SIX2 SOS1 | 2.31e-04 | 1372 | 68 | 17 | MP:0000428 |
| MousePheno | craniofacial phenotype | EPS8L2 KMT2D NFATC3 CECR2 HPS4 DZIP1L MPLKIP AMBRA1 MAFB TSHZ1 BCL2 DLX5 ZMIZ1 FIGN CREBBP SIX2 SOS1 | 2.31e-04 | 1372 | 68 | 17 | MP:0005382 |
| MousePheno | abnormal snout morphology | 2.44e-04 | 257 | 68 | 7 | MP:0000443 | |
| MousePheno | abnormal inner ear canal morphology | 2.46e-04 | 63 | 68 | 4 | MP:0002729 | |
| MousePheno | abnormal head morphology | EPS8L2 KMT2D NFATC3 CECR2 HPS4 DZIP1L MPLKIP AMBRA1 TSHZ1 BCL2 DLX5 FIGN CREBBP SIX2 SOS1 | 2.54e-04 | 1120 | 68 | 15 | MP:0000432 |
| MousePheno | abnormal membranous labyrinth morphology | 2.74e-04 | 262 | 68 | 7 | MP:0000035 | |
| MousePheno | perinatal lethality | MYC KMT2C ARID1B CECR2 HLX MAST1 MAFB TSHZ1 DLX5 KDM6B KMT2E ARID1A CREBBP TCF7L1 SIX2 | 2.80e-04 | 1130 | 68 | 15 | MP:0002081 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | KMT2C ARID1B BICRA HLX MAST1 AMBRA1 MAFB TSHZ1 DLX5 KDM6B KMT2E ARID1A CREBBP TCF7L1 SIX2 MYB | 3.03e-04 | 1269 | 68 | 16 | MP:0011111 |
| MousePheno | decreased pre-B cell number | 3.12e-04 | 67 | 68 | 4 | MP:0008209 | |
| MousePheno | hearing/vestibular/ear phenotype | EPS8L2 KMT2D TTBK1 P2RX2 HPS4 DZIP1L MAFB TSHZ1 PDZD7 BCL2 DLX5 BSN FIGN | 3.62e-04 | 905 | 68 | 13 | MP:0005377 |
| MousePheno | abnormal olfactory bulb granule cell layer morphology | 4.82e-04 | 7 | 68 | 2 | MP:0009949 | |
| MousePheno | abnormal hyoid bone greater horn morphology | 4.82e-04 | 7 | 68 | 2 | MP:0009913 | |
| MousePheno | abnormal inner hair cell synaptic ribbon morphology | 4.82e-04 | 7 | 68 | 2 | MP:0004562 | |
| MousePheno | abnormal temporal bone petrous part morphology | 4.94e-04 | 32 | 68 | 3 | MP:0030319 | |
| MousePheno | perinatal lethality, complete penetrance | KMT2C ARID1B HLX MAST1 MAFB TSHZ1 DLX5 KDM6B ARID1A TCF7L1 SIX2 | 5.96e-04 | 712 | 68 | 11 | MP:0011089 |
| MousePheno | decreased vascular endothelial cell number | 6.41e-04 | 8 | 68 | 2 | MP:0006057 | |
| MousePheno | absent endolymphatic duct | 6.41e-04 | 8 | 68 | 2 | MP:0000041 | |
| MousePheno | large anterior fontanelle | 6.41e-04 | 8 | 68 | 2 | MP:0000085 | |
| MousePheno | abnormal anterior fontanelle morphology | 6.41e-04 | 8 | 68 | 2 | MP:0030363 | |
| MousePheno | abnormal malleus processus brevis morphology | 6.41e-04 | 8 | 68 | 2 | MP:0010324 | |
| Domain | BAF250_C | 1.77e-05 | 2 | 79 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.77e-05 | 2 | 79 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.77e-05 | 2 | 79 | 2 | IPR021906 | |
| Domain | HMG_box | 7.42e-05 | 53 | 79 | 4 | PF00505 | |
| Domain | HMG | 7.98e-05 | 54 | 79 | 4 | SM00398 | |
| Domain | DUF1908 | 1.05e-04 | 4 | 79 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 1.05e-04 | 4 | 79 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 1.05e-04 | 4 | 79 | 2 | IPR023142 | |
| Domain | - | 1.05e-04 | 4 | 79 | 2 | 1.20.1480.20 | |
| Domain | HMG_box_dom | 1.65e-04 | 65 | 79 | 4 | IPR009071 | |
| Domain | FYrich_C | 1.75e-04 | 5 | 79 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.75e-04 | 5 | 79 | 2 | IPR003888 | |
| Domain | FYRC | 1.75e-04 | 5 | 79 | 2 | SM00542 | |
| Domain | FYRN | 1.75e-04 | 5 | 79 | 2 | SM00541 | |
| Domain | FYRN | 1.75e-04 | 5 | 79 | 2 | PF05964 | |
| Domain | FYRC | 1.75e-04 | 5 | 79 | 2 | PF05965 | |
| Domain | FYRC | 1.75e-04 | 5 | 79 | 2 | PS51543 | |
| Domain | FYRN | 1.75e-04 | 5 | 79 | 2 | PS51542 | |
| Domain | SET | 6.92e-04 | 41 | 79 | 3 | PF00856 | |
| Domain | Pkinase_C | 7.42e-04 | 42 | 79 | 3 | PF00433 | |
| Domain | SET | 9.70e-04 | 46 | 79 | 3 | SM00317 | |
| Domain | SET_dom | 1.24e-03 | 50 | 79 | 3 | IPR001214 | |
| Domain | SET | 1.24e-03 | 50 | 79 | 3 | PS50280 | |
| Domain | - | 1.63e-03 | 55 | 79 | 3 | 1.10.30.10 | |
| Domain | AGC-kinase_C | 1.72e-03 | 56 | 79 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.72e-03 | 56 | 79 | 3 | PS51285 | |
| Domain | S_TK_X | 1.72e-03 | 56 | 79 | 3 | SM00133 | |
| Domain | - | 1.79e-03 | 15 | 79 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.79e-03 | 15 | 79 | 2 | SM00501 | |
| Domain | ARID_dom | 1.79e-03 | 15 | 79 | 2 | IPR001606 | |
| Domain | ARID | 1.79e-03 | 15 | 79 | 2 | PS51011 | |
| Domain | ARID | 1.79e-03 | 15 | 79 | 2 | PF01388 | |
| Domain | Post-SET_dom | 2.04e-03 | 16 | 79 | 2 | IPR003616 | |
| Domain | PostSET | 2.04e-03 | 16 | 79 | 2 | SM00508 | |
| Domain | AT_hook | 2.04e-03 | 16 | 79 | 2 | PF02178 | |
| Domain | POST_SET | 2.04e-03 | 16 | 79 | 2 | PS50868 | |
| Domain | - | 2.90e-03 | 449 | 79 | 7 | 3.30.40.10 | |
| Domain | HTH_motif | 3.12e-03 | 69 | 79 | 3 | IPR000047 | |
| Domain | Znf_RING/FYVE/PHD | 3.27e-03 | 459 | 79 | 7 | IPR013083 | |
| Domain | Znf_FYVE_PHD | 3.50e-03 | 147 | 79 | 4 | IPR011011 | |
| Domain | EPHD | 3.86e-03 | 22 | 79 | 2 | PS51805 | |
| Domain | PHD | 3.95e-03 | 75 | 79 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 4.57e-03 | 79 | 79 | 3 | IPR019787 | |
| Domain | Bromodomain_CS | 5.38e-03 | 26 | 79 | 2 | IPR018359 | |
| Domain | ZINC_FINGER_C2H2_1 | 5.44e-03 | 777 | 79 | 9 | PS00028 | |
| Domain | Znf_C2H2-like | 6.34e-03 | 796 | 79 | 9 | IPR015880 | |
| Domain | PHD | 6.37e-03 | 89 | 79 | 3 | SM00249 | |
| Domain | Znf_PHD | 6.77e-03 | 91 | 79 | 3 | IPR001965 | |
| Domain | ZnF_C2H2 | 6.97e-03 | 808 | 79 | 9 | SM00355 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.59e-03 | 31 | 79 | 2 | IPR000637 | |
| Domain | ZF_PHD_2 | 7.63e-03 | 95 | 79 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 7.85e-03 | 96 | 79 | 3 | PS01359 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.84e-07 | 65 | 55 | 6 | M39682 | |
| Pathway | PID_IL2_PI3K_PATHWAY | 8.82e-06 | 34 | 55 | 4 | M143 | |
| Pathway | REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER | 3.68e-05 | 17 | 55 | 3 | M48248 | |
| Pathway | PID_NFAT_3PATHWAY | 5.27e-05 | 53 | 55 | 4 | M113 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 6.73e-05 | 110 | 55 | 5 | M48043 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.40e-04 | 68 | 55 | 4 | M48322 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.90e-04 | 137 | 55 | 5 | M48232 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.91e-04 | 29 | 55 | 3 | M48076 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 2.12e-04 | 30 | 55 | 3 | M234 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.22e-04 | 6 | 55 | 2 | M47736 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.34e-04 | 31 | 55 | 3 | M39522 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MYC KMT2C ARID1B KMT2D TUT4 MAFB BCL2 DLX5 KDM6B ARID1A CREBBP TCF7L1 SIX2 MYB SOS1 | 2.77e-04 | 1432 | 55 | 15 | M509 |
| Pathway | WP_HEPATITIS_B_INFECTION | 2.98e-04 | 151 | 55 | 5 | M39801 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.09e-04 | 237 | 55 | 6 | M27786 | |
| Pathway | PID_CMYB_PATHWAY | 3.17e-04 | 84 | 55 | 4 | M195 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 3.66e-04 | 36 | 55 | 3 | MM1418 | |
| Pathway | KEGG_PROSTATE_CANCER | 3.96e-04 | 89 | 55 | 4 | M13191 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 3.98e-04 | 37 | 55 | 3 | M8615 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.12e-04 | 8 | 55 | 2 | M48024 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 4.12e-04 | 8 | 55 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 4.12e-04 | 8 | 55 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 4.12e-04 | 8 | 55 | 2 | M27821 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.31e-04 | 91 | 55 | 4 | M27101 | |
| Pathway | WP_IL5_SIGNALING | 5.01e-04 | 40 | 55 | 3 | M39392 | |
| Pathway | PID_FOXM1_PATHWAY | 5.01e-04 | 40 | 55 | 3 | M176 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 5.07e-04 | 95 | 55 | 4 | M48268 | |
| Pathway | WP_IL2_SIGNALING | 5.79e-04 | 42 | 55 | 3 | M39536 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.40e-04 | 101 | 55 | 4 | M39448 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.41e-04 | 272 | 55 | 6 | M29619 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 6.59e-04 | 10 | 55 | 2 | M47486 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION | 6.59e-04 | 10 | 55 | 2 | M47745 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.04e-04 | 11 | 55 | 2 | M48021 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 8.81e-04 | 110 | 55 | 4 | M39492 | |
| Pathway | WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING | 9.12e-04 | 49 | 55 | 3 | M39683 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 9.62e-04 | 12 | 55 | 2 | M47410 | |
| Pathway | PID_KIT_PATHWAY | 1.08e-03 | 52 | 55 | 3 | M231 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 1.08e-03 | 52 | 55 | 3 | M19877 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.08e-03 | 301 | 55 | 6 | MM15983 | |
| Pathway | PID_IL2_1PATHWAY | 1.28e-03 | 55 | 55 | 3 | M122 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.30e-03 | 122 | 55 | 4 | M29689 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.32e-03 | 14 | 55 | 2 | M27402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 1.32e-03 | 14 | 55 | 2 | M47975 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 1.42e-03 | 57 | 55 | 3 | M19888 | |
| Pathway | REACTOME_GASTRULATION | 1.59e-03 | 129 | 55 | 4 | M46433 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.61e-03 | 325 | 55 | 6 | M12868 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 16 | 55 | 2 | M47373 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.73e-03 | 16 | 55 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.73e-03 | 16 | 55 | 2 | MM1420 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.73e-03 | 16 | 55 | 2 | M39882 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.81e-03 | 62 | 55 | 3 | M14631 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.89e-03 | 63 | 55 | 3 | M39623 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 1.96e-03 | 17 | 55 | 2 | MM1508 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.96e-03 | 17 | 55 | 2 | M48025 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 1.96e-03 | 17 | 55 | 2 | M10401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION | 1.96e-03 | 17 | 55 | 2 | M47742 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 2.07e-03 | 65 | 55 | 3 | M39374 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYC KMT2D HIVEP1 ZBTB48 NFATC3 GLI1 HLF AKNA HLX MAFB TSHZ1 DLX5 SOX8 TCF7L1 SIX2 MYB | 3.41e-10 | 908 | 82 | 16 | 19274049 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | KMT2C ARID1B KMT2D HIVEP1 BICRA CECR2 TSHZ1 ARID1A NCKAP5L CREBBP | 3.54e-08 | 398 | 82 | 10 | 35016035 |
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 34645806 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 28398509 | ||
| Pubmed | 8.37e-08 | 233 | 82 | 8 | 37704626 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | KMT2C ARID1B KMT2D ATXN2 GLI1 PUM2 NUP214 ZMIZ1 ARID1A CREBBP | 1.28e-07 | 457 | 82 | 10 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.50e-07 | 351 | 82 | 9 | 38297188 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 1.67e-07 | 21 | 82 | 4 | 27626377 | |
| Pubmed | MYC KMT2C HIVEP1 BICRA HPS4 NUP214 KIF5B NCKAP5L CREBBP SOS1 | 2.25e-07 | 486 | 82 | 10 | 20936779 | |
| Pubmed | 2.45e-07 | 57 | 82 | 5 | 18022353 | ||
| Pubmed | 2.51e-07 | 6 | 82 | 3 | 8896557 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NHSL1 KMT2C CRYBG2 KMT2D BICRA GLI1 SORBS3 ADGRB2 AKNA AMBRA1 NUP214 KDM6B ARID1A MAST2 | 2.89e-07 | 1105 | 82 | 14 | 35748872 |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 7.01e-07 | 8 | 82 | 3 | 23130995 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 8.20e-07 | 430 | 82 | 9 | 35044719 | |
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 35678316 | ||
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 10619357 | ||
| Pubmed | MYC KMT2C ARID1B KMT2D HIVEP1 ATXN2 NFATC3 BICRA PUM2 NUP214 ZMIZ1 FIGN ARID1A CREBBP MYB | 1.12e-06 | 1429 | 82 | 15 | 35140242 | |
| Pubmed | 1.42e-06 | 35 | 82 | 4 | 32504627 | ||
| Pubmed | 1.68e-06 | 469 | 82 | 9 | 27634302 | ||
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 12482968 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34980601 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 8670887 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19535347 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22851565 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 35231992 | ||
| Pubmed | A dominant interfering Myb mutant causes apoptosis in T cells. | 5.49e-06 | 2 | 82 | 2 | 8946914 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18752503 | ||
| Pubmed | The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas. | 5.49e-06 | 2 | 82 | 2 | 32334477 | |
| Pubmed | Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer. | 5.49e-06 | 2 | 82 | 2 | 33799592 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27286976 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29044419 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32717030 | ||
| Pubmed | Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma. | 5.49e-06 | 2 | 82 | 2 | 26421520 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29801406 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23449635 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28212447 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23980173 | ||
| Pubmed | Transport of c-MYC by Kinesin-1 for proteasomal degradation in the cytoplasm. | 5.49e-06 | 2 | 82 | 2 | 24821626 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 31924266 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34739417 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32101329 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11848471 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 5.49e-06 | 2 | 82 | 2 | 37611161 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32791957 | ||
| Pubmed | Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma. | 5.49e-06 | 2 | 82 | 2 | 29198442 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 37996430 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28967912 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18493992 | ||
| Pubmed | Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression. | 5.49e-06 | 2 | 82 | 2 | 34862309 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 5.49e-06 | 2 | 82 | 2 | 28967863 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26158410 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27544800 | ||
| Pubmed | Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. | 5.49e-06 | 2 | 82 | 2 | 15019774 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22484426 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25828389 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19597184 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23939148 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 31127909 | ||
| Pubmed | CREB-mediated Bcl-2 expression in trichosanthin-induced Hela cell apoptosis. | 5.49e-06 | 2 | 82 | 2 | 17825790 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 5.49e-06 | 2 | 82 | 2 | 27999180 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22002575 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18382371 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22804688 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20118770 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 36601880 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28483418 | ||
| Pubmed | c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation. | 5.49e-06 | 2 | 82 | 2 | 12525485 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34386776 | ||
| Pubmed | Effects of depletion of CREB-binding protein on c-Myc regulation and cell cycle G1-S transition. | 5.49e-06 | 2 | 82 | 2 | 15522869 | |
| Pubmed | Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma. | 5.49e-06 | 2 | 82 | 2 | 23525267 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23202128 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21640157 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26558423 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 31844144 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33890484 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 5.49e-06 | 2 | 82 | 2 | 34156443 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28327893 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19395026 | ||
| Pubmed | Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas. | 5.49e-06 | 2 | 82 | 2 | 22949148 | |
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 5.49e-06 | 2 | 82 | 2 | 24562383 | |
| Pubmed | Presence of regulatory sequences within intron 4 of human and murine c-myb genes. | 5.49e-06 | 2 | 82 | 2 | 7918623 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26390147 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21628855 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27280393 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33120427 | ||
| Pubmed | WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells. | 5.49e-06 | 2 | 82 | 2 | 19890377 | |
| Pubmed | Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. | 5.49e-06 | 2 | 82 | 2 | 11073948 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 38039509 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27391453 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 5.49e-06 | 2 | 82 | 2 | 29890703 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32566654 | ||
| Pubmed | Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL. | 5.49e-06 | 2 | 82 | 2 | 26634708 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 36869380 | ||
| Pubmed | Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma. | 5.49e-06 | 2 | 82 | 2 | 17317859 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27071312 | ||
| Pubmed | [Expression of c-myc and c-myb gene in leukemic bone marrow stromal cells and their correlation]. | 5.49e-06 | 2 | 82 | 2 | 22739149 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26515759 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24788099 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33689920 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25741152 | ||
| Interaction | DYNLL2 interactions | MYC NHSL1 CDC42BPG KMT2C OPTN ZSCAN5A DZIP1L TAX1BP1 MAST1 AMBRA1 BSN | 7.18e-09 | 263 | 80 | 11 | int:DYNLL2 |
| Interaction | TLE3 interactions | MYC CBLL1 ARID1B KMT2D HIVEP1 CECR2 HLX ZMIZ1 FIGN ARID1A CREBBP SIX2 | 2.88e-08 | 376 | 80 | 12 | int:TLE3 |
| Interaction | GCM1 interactions | 2.91e-07 | 68 | 80 | 6 | int:GCM1 | |
| Interaction | E2F5 interactions | 2.97e-07 | 36 | 80 | 5 | int:E2F5 | |
| Interaction | SP7 interactions | MYC KMT2C ARID1B KMT2D HIVEP1 BICRA DLX5 ZMIZ1 ARID1A CREBBP | 3.41e-07 | 304 | 80 | 10 | int:SP7 |
| Interaction | EGR2 interactions | 3.93e-07 | 171 | 80 | 8 | int:EGR2 | |
| Interaction | SOX7 interactions | 8.91e-07 | 82 | 80 | 6 | int:SOX7 | |
| Interaction | FOS interactions | 4.03e-06 | 312 | 80 | 9 | int:FOS | |
| Interaction | PAX8 interactions | 5.26e-06 | 111 | 80 | 6 | int:PAX8 | |
| Interaction | TBR1 interactions | 5.83e-06 | 113 | 80 | 6 | int:TBR1 | |
| Interaction | NUP35 interactions | KMT2C ARID1B KMT2D ATXN2 GLI1 PUM2 NUP214 ZMIZ1 ARID1A CREBBP | 6.77e-06 | 424 | 80 | 10 | int:NUP35 |
| Interaction | TBXT interactions | 6.78e-06 | 116 | 80 | 6 | int:TBXT | |
| Interaction | ETV4 interactions | 8.00e-06 | 69 | 80 | 5 | int:ETV4 | |
| Interaction | ETS1 interactions | 8.65e-06 | 121 | 80 | 6 | int:ETS1 | |
| Interaction | LHX3 interactions | 8.85e-06 | 185 | 80 | 7 | int:LHX3 | |
| Interaction | NFIA interactions | 9.83e-06 | 188 | 80 | 7 | int:NFIA | |
| Interaction | PAX7 interactions | 9.95e-06 | 124 | 80 | 6 | int:PAX7 | |
| Interaction | HNF1B interactions | 1.05e-05 | 190 | 80 | 7 | int:HNF1B | |
| Interaction | GATA2 interactions | 1.42e-05 | 199 | 80 | 7 | int:GATA2 | |
| Interaction | FEV interactions | 1.62e-05 | 203 | 80 | 7 | int:FEV | |
| Interaction | HLF interactions | 1.67e-05 | 13 | 80 | 3 | int:HLF | |
| Interaction | RBBP5 interactions | 1.83e-05 | 287 | 80 | 8 | int:RBBP5 | |
| Interaction | HPS1 interactions | 2.12e-05 | 14 | 80 | 3 | int:HPS1 | |
| Interaction | NFIB interactions | 2.15e-05 | 142 | 80 | 6 | int:NFIB | |
| Interaction | SMAD2 interactions | 2.16e-05 | 385 | 80 | 9 | int:SMAD2 | |
| Interaction | GSC interactions | 2.49e-05 | 87 | 80 | 5 | int:GSC | |
| Interaction | ERG interactions | 2.96e-05 | 223 | 80 | 7 | int:ERG | |
| Interaction | SOX10 interactions | 3.26e-05 | 92 | 80 | 5 | int:SOX10 | |
| Interaction | FOXI1 interactions | 3.26e-05 | 92 | 80 | 5 | int:FOXI1 | |
| Interaction | SOX9 interactions | 4.21e-05 | 97 | 80 | 5 | int:SOX9 | |
| Interaction | KLF4 interactions | 4.22e-05 | 160 | 80 | 6 | int:KLF4 | |
| Interaction | SS18L1 interactions | 4.42e-05 | 98 | 80 | 5 | int:SS18L1 | |
| Interaction | FXR2 interactions | 5.12e-05 | 430 | 80 | 9 | int:FXR2 | |
| Interaction | LHX4 interactions | 5.18e-05 | 166 | 80 | 6 | int:LHX4 | |
| Interaction | LHX1 interactions | 5.61e-05 | 103 | 80 | 5 | int:LHX1 | |
| Interaction | CRX interactions | 6.75e-05 | 254 | 80 | 7 | int:CRX | |
| Interaction | TLX1 interactions | 6.95e-05 | 175 | 80 | 6 | int:TLX1 | |
| Interaction | TEAD1 interactions | 7.17e-05 | 176 | 80 | 6 | int:TEAD1 | |
| Interaction | TPRX2 interactions | 7.23e-05 | 56 | 80 | 4 | int:TPRX2 | |
| Interaction | ASH2L interactions | 8.80e-05 | 265 | 80 | 7 | int:ASH2L | |
| Interaction | GATA3 interactions | 1.00e-04 | 187 | 80 | 6 | int:GATA3 | |
| Interaction | PAX6 interactions | 1.02e-04 | 366 | 80 | 8 | int:PAX6 | |
| Interaction | HNF4A interactions | 1.11e-04 | 275 | 80 | 7 | int:HNF4A | |
| Interaction | NANOG interactions | 1.20e-04 | 481 | 80 | 9 | int:NANOG | |
| Interaction | MYOD1 interactions | 1.23e-04 | 194 | 80 | 6 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.26e-04 | 195 | 80 | 6 | int:KLF5 | |
| Interaction | PAX9 interactions | 1.69e-04 | 130 | 80 | 5 | int:PAX9 | |
| Interaction | CXXC1 interactions | 1.81e-04 | 132 | 80 | 5 | int:CXXC1 | |
| Interaction | TOP3B interactions | NHSL1 KMT2C CRYBG2 KMT2D ATXN2 BICRA GLI1 SORBS3 ADGRB2 AKNA AMBRA1 NUP214 KDM6B ARID1A MAST2 ADAMTSL4 | 1.84e-04 | 1470 | 80 | 16 | int:TOP3B |
| Interaction | MYB interactions | 1.88e-04 | 133 | 80 | 5 | int:MYB | |
| Interaction | NFIC interactions | 1.89e-04 | 210 | 80 | 6 | int:NFIC | |
| Interaction | PPARG interactions | 2.18e-04 | 307 | 80 | 7 | int:PPARG | |
| Interaction | POU1F1 interactions | 2.50e-04 | 31 | 80 | 3 | int:POU1F1 | |
| Interaction | ZBTB17 interactions | 2.50e-04 | 77 | 80 | 4 | int:ZBTB17 | |
| Interaction | KMT2A interactions | 2.50e-04 | 314 | 80 | 7 | int:KMT2A | |
| Interaction | CHUK interactions | 2.67e-04 | 224 | 80 | 6 | int:CHUK | |
| Interaction | FMR1 interactions | 2.70e-04 | 536 | 80 | 9 | int:FMR1 | |
| Interaction | GABARAP interactions | 2.80e-04 | 145 | 80 | 5 | int:GABARAP | |
| Interaction | NFIX interactions | 2.87e-04 | 227 | 80 | 6 | int:NFIX | |
| Interaction | SDC4 interactions | 3.18e-04 | 82 | 80 | 4 | int:SDC4 | |
| Interaction | IKBKB interactions | 3.30e-04 | 233 | 80 | 6 | int:IKBKB | |
| Interaction | PAX2 interactions | 3.65e-04 | 85 | 80 | 4 | int:PAX2 | |
| Interaction | IRF4 interactions | 3.65e-04 | 85 | 80 | 4 | int:IRF4 | |
| Interaction | HOXB2 interactions | 3.91e-04 | 36 | 80 | 3 | int:HOXB2 | |
| Interaction | SMAD3 interactions | 3.95e-04 | 447 | 80 | 8 | int:SMAD3 | |
| Interaction | SS18 interactions | 4.17e-04 | 88 | 80 | 4 | int:SS18 | |
| Interaction | MAFK interactions | 4.25e-04 | 37 | 80 | 3 | int:MAFK | |
| Interaction | PHF21A interactions | 4.26e-04 | 343 | 80 | 7 | int:PHF21A | |
| Interaction | ZNF66 interactions | 4.29e-04 | 8 | 80 | 2 | int:ZNF66 | |
| Interaction | ASF1A interactions | 4.69e-04 | 249 | 80 | 6 | int:ASF1A | |
| Interaction | ITCH interactions | 5.32e-04 | 356 | 80 | 7 | int:ITCH | |
| Interaction | BRAT1 interactions | 5.35e-04 | 94 | 80 | 4 | int:BRAT1 | |
| Interaction | HELZ interactions | 5.54e-04 | 257 | 80 | 6 | int:HELZ | |
| Interaction | SOX17 interactions | 5.57e-04 | 95 | 80 | 4 | int:SOX17 | |
| Interaction | DPF3 interactions | 5.57e-04 | 95 | 80 | 4 | int:DPF3 | |
| Interaction | DPF1 interactions | 5.57e-04 | 95 | 80 | 4 | int:DPF1 | |
| Interaction | SETD1A interactions | 5.81e-04 | 170 | 80 | 5 | int:SETD1A | |
| Interaction | CREBBP interactions | 6.05e-04 | 599 | 80 | 9 | int:CREBBP | |
| Interaction | SMARCB1 interactions | 6.07e-04 | 364 | 80 | 7 | int:SMARCB1 | |
| Interaction | CHERP interactions | 6.13e-04 | 262 | 80 | 6 | int:CHERP | |
| Interaction | TIFA interactions | 6.18e-04 | 42 | 80 | 3 | int:TIFA | |
| Interaction | GCC1 interactions | 6.51e-04 | 99 | 80 | 4 | int:GCC1 | |
| Interaction | ATP5F1EP2 interactions | 6.86e-04 | 10 | 80 | 2 | int:ATP5F1EP2 | |
| Interaction | UTF1 interactions | 6.86e-04 | 10 | 80 | 2 | int:UTF1 | |
| Interaction | ARID1B interactions | 6.97e-04 | 177 | 80 | 5 | int:ARID1B | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.57e-04 | 34 | 56 | 3 | 487 | |
| GeneFamily | AT-rich interaction domain containing | 9.64e-04 | 15 | 56 | 2 | 418 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.70e-03 | 25 | 56 | 2 | 775 | |
| GeneFamily | PHD finger proteins | 2.73e-03 | 90 | 56 | 3 | 88 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 2.11e-07 | 199 | 82 | 8 | M9420 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CDC42BPG KMT2C TMTC1 OPTN HIVEP1 USP42 HLX PUM2 MAFB KIF5B CREBBP ARHGEF15 | 1.35e-05 | 854 | 82 | 12 | M1533 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC TUT4 HIVEP1 ATXN2 NFATC3 MICAL2 PUM2 ZMIZ1 MAST2 WASF1 CREBBP SOS1 | 1.38e-05 | 856 | 82 | 12 | M4500 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CDC42BPG KMT2C TMTC1 OPTN HIVEP1 USP42 HLX PUM2 MAFB KIF5B CREBBP ARHGEF15 | 1.99e-05 | 888 | 82 | 12 | MM1018 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.19e-05 | 180 | 82 | 6 | M8239 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN | 3.85e-05 | 199 | 82 | 6 | M9744 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 3.85e-05 | 199 | 82 | 6 | M7374 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN | 3.96e-05 | 200 | 82 | 6 | M5966 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP | 3.96e-05 | 200 | 82 | 6 | M6836 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 4.07e-05 | 201 | 82 | 6 | MM17086 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 8.18e-05 | 228 | 82 | 6 | MM1014 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.06e-04 | 466 | 82 | 8 | M13522 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-06 | 192 | 82 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-06 | 193 | 82 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.71e-06 | 154 | 82 | 5 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.10e-05 | 158 | 82 | 5 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.32e-05 | 164 | 82 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 167 | 82 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 175 | 82 | 5 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 2.17e-05 | 182 | 82 | 5 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.23e-05 | 183 | 82 | 5 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 185 | 82 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.41e-05 | 186 | 82 | 5 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 188 | 82 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 190 | 82 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 191 | 82 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 191 | 82 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 193 | 82 | 5 | 45205ad1ef12aabf33059a7ff922a3bb86994c2f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 193 | 82 | 5 | 1beca3d3b34082b7d9112fbd094bee8019921ca0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 193 | 82 | 5 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.18e-05 | 197 | 82 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | severe_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.18e-05 | 197 | 82 | 5 | cdffd49db7374d223ded46d636cd4be12d464ea4 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.18e-05 | 197 | 82 | 5 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.18e-05 | 197 | 82 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-05 | 198 | 82 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-05 | 198 | 82 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.33e-05 | 199 | 82 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.13e-04 | 135 | 82 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | RV-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.20e-04 | 137 | 82 | 4 | 97f090732bc73db1cff050b1d6380b5ecc9a95e5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 148 | 82 | 4 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.65e-04 | 149 | 82 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 151 | 82 | 4 | 28e3f77d2edb30fcf1414762a55ceffaf879d526 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 151 | 82 | 4 | 688cc5e4d46ba16f9b431352d7a6d39b21941e9c | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.74e-04 | 151 | 82 | 4 | 45392bb1c6358beff33da0ca84f7696fb5824f30 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-04 | 151 | 82 | 4 | 3d861285c71abe220b19a069eb9876199c6c8f39 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 155 | 82 | 4 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 157 | 82 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.07e-04 | 158 | 82 | 4 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.17e-04 | 160 | 82 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 162 | 82 | 4 | f2a87019ff9b466617e90c60d182ab7d14581cc9 | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 165 | 82 | 4 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.44e-04 | 165 | 82 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.50e-04 | 166 | 82 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 169 | 82 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.67e-04 | 169 | 82 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-04 | 170 | 82 | 4 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 172 | 82 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 172 | 82 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.92e-04 | 173 | 82 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 174 | 82 | 4 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 174 | 82 | 4 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 2.99e-04 | 174 | 82 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 176 | 82 | 4 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 176 | 82 | 4 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 178 | 82 | 4 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 178 | 82 | 4 | a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.26e-04 | 178 | 82 | 4 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.40e-04 | 180 | 82 | 4 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 3.40e-04 | 180 | 82 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 180 | 82 | 4 | 0c5d9245b8a7cc34ad52522d31559906cda55bdf | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.47e-04 | 181 | 82 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 3.47e-04 | 181 | 82 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 181 | 82 | 4 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.54e-04 | 182 | 82 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 3.54e-04 | 182 | 82 | 4 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 99ab7a43527eb226027efbcd8c0b6a8e46fc3c93 | |
| ToppCell | HSPCs-LMPPs|World / Lineage and Cell class | 3.62e-04 | 183 | 82 | 4 | e401f06843528a75693ce455bbeff2a98b8c24e5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 183 | 82 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 28916f0597690ff534578be2cb715b485cb1de1a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 184 | 82 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.77e-04 | 185 | 82 | 4 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.77e-04 | 185 | 82 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.77e-04 | 185 | 82 | 4 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-04 | 186 | 82 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-04 | 186 | 82 | 4 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-04 | 186 | 82 | 4 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.85e-04 | 186 | 82 | 4 | c7983281a290201567b398e9ea6baddb96c692bb | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 3.85e-04 | 186 | 82 | 4 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-04 | 186 | 82 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 186 | 82 | 4 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-04 | 186 | 82 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.85e-04 | 186 | 82 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.85e-04 | 186 | 82 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 3.85e-04 | 186 | 82 | 4 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 187 | 82 | 4 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.92e-04 | 187 | 82 | 4 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.92e-04 | 187 | 82 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; HL60; HG-U133A | 5.69e-06 | 195 | 80 | 7 | 1984_UP | |
| Drug | Diethylstilbestrol | MYC ZP1 KMT2C KMT2D CFAP126 NFATC3 MICAL2 GLI1 ADGRB2 QPCT MAFB BCL2 DLX5 FXYD3 CREBBP MYB | 1.03e-05 | 1305 | 80 | 16 | ctd:D004054 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.55e-05 | 165 | 80 | 6 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-05 | 169 | 80 | 6 | 6064_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-05 | 172 | 80 | 6 | 3428_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.22e-05 | 172 | 80 | 6 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.33e-05 | 173 | 80 | 6 | 5336_DN | |
| Drug | 3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine | 3.65e-05 | 3 | 80 | 2 | ctd:C542465 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 6434_DN | |
| Drug | scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A | 4.03e-05 | 179 | 80 | 6 | 6901_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 5.62e-05 | 190 | 80 | 6 | 1172_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.95e-05 | 192 | 80 | 6 | 6978_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 6.31e-05 | 194 | 80 | 6 | 6660_DN | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7198_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2953_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 4606_DN | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 1751_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6300_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; HL60; HG-U133A | 7.06e-05 | 198 | 80 | 6 | 1983_UP | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 6394_UP | |
| Drug | glyfoline | 7.28e-05 | 4 | 80 | 2 | CID005480208 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.04e-07 | 55 | 80 | 5 | C0079744 | |
| Disease | Sezary Syndrome | 8.38e-07 | 27 | 80 | 4 | C0036920 | |
| Disease | monocyte count | CRYBG2 HIVEP1 ATXN2 ZSCAN5A CECR2 HLX MAST1 MAFB ST6GALNAC4 BCL2 ZMIZ1 MAST2 TDRD1 TCF7L1 MYB | 2.28e-06 | 1320 | 80 | 15 | EFO_0005091 |
| Disease | Bladder Neoplasm | 2.31e-06 | 140 | 80 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.40e-06 | 141 | 80 | 6 | C0005684 | |
| Disease | prostate cancer (is_marker_for) | 4.31e-06 | 156 | 80 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 7.26e-06 | 2 | 80 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 7.94e-06 | 100 | 80 | 5 | C0010606 | |
| Disease | Lymphoma, Follicular, Grade 2 | 8.53e-06 | 15 | 80 | 3 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 8.53e-06 | 15 | 80 | 3 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 8.53e-06 | 15 | 80 | 3 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 8.53e-06 | 15 | 80 | 3 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 8.53e-06 | 15 | 80 | 3 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 8.53e-06 | 15 | 80 | 3 | C0079758 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.33e-05 | 53 | 80 | 4 | C1961099 | |
| Disease | neutrophil count | HIVEP1 ATXN2 MICAL2 HLX MAFB BCL2 ZMIZ1 KDM6B KMT2E ARID1A MAST2 CREBBP TCF7L1 MYB | 1.90e-05 | 1382 | 80 | 14 | EFO_0004833 |
| Disease | Lymphoma, Follicular | 2.12e-05 | 20 | 80 | 3 | C0024301 | |
| Disease | monocyte percentage of leukocytes | 2.83e-05 | 731 | 80 | 10 | EFO_0007989 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 7.22e-05 | 5 | 80 | 2 | C3281201 | |
| Disease | Klatskin's tumor (is_implicated_in) | 7.22e-05 | 5 | 80 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | lymphocyte percentage of leukocytes | 7.93e-05 | 665 | 80 | 9 | EFO_0007993 | |
| Disease | anthropometric measurement | 9.60e-05 | 168 | 80 | 5 | EFO_0004302 | |
| Disease | acute promyelocytic leukemia (is_marker_for) | 1.08e-04 | 6 | 80 | 2 | DOID:0060318 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 1.10e-04 | 173 | 80 | 5 | C0023467 | |
| Disease | age of onset of childhood onset asthma | 1.17e-04 | 92 | 80 | 4 | OBA_2001015 | |
| Disease | Burkitt Lymphoma | 1.28e-04 | 36 | 80 | 3 | C0006413 | |
| Disease | testosterone measurement | ARID1B TTBK1 CECR2 HLF AKNA MAFB BCL2 ZMIZ1 KDM6B ARID1A ARHGEF15 SOS1 | 1.60e-04 | 1275 | 80 | 12 | EFO_0004908 |
| Disease | Carcinoma, Transitional Cell | 1.90e-04 | 41 | 80 | 3 | C0007138 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.93e-04 | 195 | 80 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | colorectal cancer, endometrial neoplasm | 2.04e-04 | 42 | 80 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.19e-04 | 43 | 80 | 3 | DOID:9261 (is_marker_for) | |
| Disease | total blood protein measurement | 2.20e-04 | 449 | 80 | 7 | EFO_0004536 | |
| Disease | neutrophil percentage of leukocytes | 2.50e-04 | 610 | 80 | 8 | EFO_0007990 | |
| Disease | Carcinoma, Granular Cell | 2.85e-04 | 116 | 80 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.85e-04 | 116 | 80 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.85e-04 | 116 | 80 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.85e-04 | 116 | 80 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.85e-04 | 116 | 80 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.85e-04 | 116 | 80 | 4 | C0001418 | |
| Disease | Neuroblastoma | 2.86e-04 | 47 | 80 | 3 | C0027819 | |
| Disease | neuroblastoma (is_implicated_in) | 3.22e-04 | 10 | 80 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Acute Myeloid Leukemia, M1 | 3.78e-04 | 125 | 80 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.78e-04 | 125 | 80 | 4 | C1879321 | |
| Disease | Metastatic melanoma | 4.31e-04 | 54 | 80 | 3 | C0278883 | |
| Disease | Chronic Lymphocytic Leukemia | 4.55e-04 | 55 | 80 | 3 | C0023434 | |
| Disease | Secondary Open Angle Glaucoma | 4.71e-04 | 12 | 80 | 2 | C0271148 | |
| Disease | intracranial aneurysm (is_implicated_in) | 4.71e-04 | 12 | 80 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Glaucoma, Open-Angle | 4.71e-04 | 12 | 80 | 2 | C0017612 | |
| Disease | Coffin-Siris syndrome | 5.55e-04 | 13 | 80 | 2 | C0265338 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 5.55e-04 | 13 | 80 | 2 | C1846647 | |
| Disease | Glaucoma, Primary Open Angle | 5.55e-04 | 13 | 80 | 2 | C0339573 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 5.65e-04 | 139 | 80 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 6.12e-04 | 142 | 80 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 6.17e-04 | 61 | 80 | 3 | C1961102 | |
| Disease | Malignant neoplasm of breast | ARID1B KMT2D GLI1 TAX1BP1 MPLKIP BCL2 NUP214 ZMIZ1 ARID1A TCF7L1 | 6.40e-04 | 1074 | 80 | 10 | C0006142 |
| Disease | African Burkitt's lymphoma | 7.45e-04 | 15 | 80 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 7.45e-04 | 15 | 80 | 2 | C4721444 | |
| Disease | T-Cell Lymphoma | 8.50e-04 | 16 | 80 | 2 | C0079772 | |
| Disease | congenital heart disease (implicated_via_orthology) | 8.84e-04 | 69 | 80 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 1.13e-03 | 592 | 80 | 7 | EFO_0004535 | |
| Disease | Nonsyndromic Deafness | 1.41e-03 | 81 | 80 | 3 | C3711374 | |
| Disease | Prostatic Neoplasms | 1.42e-03 | 616 | 80 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.42e-03 | 616 | 80 | 7 | C0376358 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.56e-03 | 84 | 80 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Lymphoma, Small Noncleaved-Cell | 1.62e-03 | 22 | 80 | 2 | C0079770 | |
| Disease | colorectal cancer, hormone replacement therapy | 1.78e-03 | 88 | 80 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.93e-03 | 24 | 80 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.93e-03 | 24 | 80 | 2 | C3805278 | |
| Disease | Neurodevelopmental Disorders | 2.09e-03 | 93 | 80 | 3 | C1535926 | |
| Disease | apolipoprotein A 1 measurement | 2.11e-03 | 848 | 80 | 8 | EFO_0004614 | |
| Disease | IGF-1 measurement | 2.12e-03 | 488 | 80 | 6 | EFO_0004627 | |
| Disease | Squamous cell carcinoma of esophagus | 2.22e-03 | 95 | 80 | 3 | C0279626 | |
| Disease | Cholangiocarcinoma | 2.26e-03 | 26 | 80 | 2 | C0206698 | |
| Disease | blood chromium measurement | 2.26e-03 | 26 | 80 | 2 | EFO_0007579 | |
| Disease | HbA1c measurement | 2.38e-03 | 675 | 80 | 7 | EFO_0004541 | |
| Disease | L-arginine measurement | 2.44e-03 | 27 | 80 | 2 | EFO_0006524 | |
| Disease | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | 2.62e-03 | 28 | 80 | 2 | EFO_0000183, EFO_0001378, EFO_0005952 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.62e-03 | 28 | 80 | 2 | DOID:5409 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPHESLRSPGTLPNH | 36 | Q9BXT4 | |
| AHPGSHSDQPPGVPS | 91 | A8MUN3 | |
| TVPPGPGHSHQRLLP | 791 | O60241 | |
| SPHPPVGPKSNRGHS | 121 | Q5RHP9 | |
| QPPPASTPGHGPSHR | 191 | O75871 | |
| HHPRAQASGTEPPSP | 251 | Q6UY14 | |
| PSPHHVSPQTGSPHP | 2371 | Q92793 | |
| TSRSRPHPPSIGHPA | 246 | O94989 | |
| SPHASPHLSSIPGGP | 791 | Q8NFD5 | |
| ERPGPSHQPTPHSSE | 541 | Q9C0C7 | |
| PTRSPPPSTLHGRSH | 401 | Q8N7E2 | |
| SINSHLPPPGSLQHP | 266 | P56178 | |
| KPHLGPGPSHQPRTL | 811 | Q9BXF3 | |
| TPHPPGARGTSQLHG | 226 | Q16769 | |
| PGHSLTPPPSLSSHG | 631 | Q8TB72 | |
| TLNHPGTLPPPSHGA | 371 | Q6DT37 | |
| PGQHPAASPTHPSAI | 926 | P33176 | |
| FSPHTSPHLPGIRGP | 681 | O14497 | |
| PAEPPPPTRQSHGSH | 566 | Q8IYY4 | |
| LPSPHPSPLHSSGLL | 206 | Q5HY92 | |
| GSPHHTPPYGPRSRP | 46 | Q8TAP9 | |
| IGSSPHLPHNSLPPG | 1566 | Q8NEZ4 | |
| QQLPTSHPGPGPHAT | 181 | Q9Y5Q3 | |
| VVPNPHHSGSAPAPS | 156 | Q14774 | |
| PLGSRPGHPHSSSQV | 416 | Q9HCH0 | |
| PGAPHNSTHTRPPGA | 51 | Q9BVV8 | |
| HPHTPHPQPSATPTG | 1141 | Q99700 | |
| HPGHSSQAPIPRADP | 446 | Q9NQG7 | |
| LPAPLPPSHGSSSGH | 56 | O15054 | |
| AGVTGPHPPSPSEIH | 711 | Q9UPA5 | |
| HSRNHSPSPPVTPTG | 1381 | Q5SYE7 | |
| SPSASAPRHPHKGIP | 701 | Q9H5P4 | |
| SPGTANGHSPEHTPP | 216 | Q7L5A3 | |
| HPPPHPSTGLQGLQA | 1691 | Q8IZD2 | |
| KHGAPSPSHPISAPQ | 1076 | P35658 | |
| PPPSHDQRGSSGHTP | 1061 | P08151 | |
| HHSTPSLPADPGSLP | 351 | P10242 | |
| HSPHPPGLQPASSAA | 106 | Q16534 | |
| PGDALPPVSSPHTHR | 471 | Q9H6S3 | |
| LPRPHSPLPGHLGSS | 46 | Q9Y2H9 | |
| ASPPPLPGHTVGSSH | 1216 | Q9Y2H9 | |
| SQTPLPGPHHPDQTR | 471 | Q75N03 | |
| PGHRSEDQHPSPPSG | 406 | Q9UBL9 | |
| SSGSLTPPGHRPPHP | 466 | P81408 | |
| PPHGGSSRLLPTQPH | 721 | Q4ZHG4 | |
| AREHGSHPVQSLPPP | 211 | P23610 | |
| HSPPASHLPRPTAGG | 246 | Q8N1P7 | |
| PPHPPGTKSAASHQS | 871 | Q7Z591 | |
| PLHSPLHTPRASPTG | 516 | Q8TDC3 | |
| SHPSAGHTPGPQRPA | 161 | Q5VTH2 | |
| STSPTLPRPHSPLHG | 181 | Q6P0Q8 | |
| PLHSKPGAPSHPQLG | 781 | Q6UXX5 | |
| SPSLPHQAPLGDSPH | 776 | Q9NZM4 | |
| VPPTSPSDHQGPPHT | 196 | Q5FWE3 | |
| SKGLSHTHPPSPPSR | 891 | O94851 | |
| PPLVQGTALHHSPPS | 1216 | Q9BZA8 | |
| PSESTGNGPPHLAHP | 16 | Q96CV9 | |
| HHPGETPPLITPGSA | 71 | Q14802 | |
| PTAPDPPSQHLRGHG | 701 | Q86VP1 | |
| AHASGRSHPASPSPP | 21 | Q6IEE7 | |
| SPSAGGHSKPPHSPL | 281 | P01106 | |
| GAPRPGSTAHPPHAI | 296 | Q5T5P2 | |
| GSTAHPPHAIPNSPP | 301 | Q5T5P2 | |
| DHTGQTHGPPTPPTT | 216 | P57073 | |
| PQTPSPHGTRRHLPS | 1261 | Q07889 | |
| PGIFSSQPGHTPHPA | 46 | P10415 | |
| SQPGHTPHPAASRDP | 51 | P10415 | |
| PRGSHSPQRPQLHSP | 166 | P10074 | |
| HFPTGSRPTVPGPLH | 41 | Q9H4F1 | |
| LTHPTHSPGQSSPRP | 421 | Q9H9J4 | |
| QPPTPGSPSHSPLHS | 631 | Q5TCY1 | |
| GSPSHSPLHSGPRPR | 636 | Q5TCY1 | |
| QPGSPQPSSLPGHPH | 256 | Q8IUR5 | |
| GHSSVHPTPALPSPG | 186 | P60852 | |
| AHPGLPTSGIPHPAI | 296 | Q9HCS4 | |
| PSSTTHIAQGAPHPP | 351 | Q76KD6 | |
| PGTHLPQGPSSRTHP | 236 | Q9BSI4 | |
| PPQHHPSGPKSSATV | 211 | Q96RF0 | |
| NSIHSPGPASPVSHP | 331 | Q9BUG6 | |
| HSPVPSPGHSPRGSV | 291 | Q12968 | |
| PGPALSHSRGPSHPL | 586 | O60504 | |
| PSLHSLGHPPGPSAV | 241 | Q9NPC8 | |
| TALAHPPSGLHPTPS | 446 | Q92558 | |
| TLTSPGPSPPSHRLH | 156 | Q53SZ7 | |
| PIHGPVIHSAPGSAP | 1506 | Q5TAX3 | |
| QPGLHHRPPSSSSGL | 181 | Q96NR7 | |
| TLQPTPGLPSPHTHL | 2366 | P15822 | |
| LHSPGSLTPPPHKSN | 621 | Q6ZSZ6 | |
| QGLHVPHPSSQSGPP | 961 | Q9ULJ6 | |
| PHPSSQSGPPLHHSG | 966 | Q9ULJ6 | |
| FHTTPPGTPRHQPST | 2226 | O14686 | |
| LHPTPHTKGPTLPTG | 2946 | O14686 |